A drug used to treat peripheral T-cell lymphoma (a fast-growing form of non-Hodgkin lymphoma) that recurred (came back) or did not get better with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Pralatrexate stops cells from using folic acid to make DNA. This may help keep cancer cells from growing and may kill them. Pralatrexate is a type of antimetabolite and a type of dihydrofolate reductase inhibitor. Also called Folotyn.
Are you looking for or in search of FDA approved “Pralatrexate injection Solution for intravenous in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for lymphoma. Need Access of “Pralatrexate injection Solution for intravenous” for oral use for oral use, get in touch with our healthcare professional.
Pralatrexate is approved to treat: Peripheral T-cell lymphoma in patients whose disease is refractory (does not respond to treatment) or has recurred (come back). Pralatrexate was approved for medical use in the United States in September 2009, as the first treatment for Peripheral T-cell Lymphoma (PTCL), an often aggressive type of non-Hodgkins lymphoma.